Skip to main content
GHRS logo

GH Research PLC

GHRSNASDAQHealthcareBiotechnology

$20.71Today:- (-)1Y +39.41%

As of Oct 28, 2026 close

Market cap
$1.38B
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$12.04$31.44
Volume (live)
-
Avg. volume (3M)
332.35K

GH Research (GHRS) Cash Flow Statement

In fiscal 2025 (fiscal year ended Dec 31, 2025), GH Research used $43.55M of cash in operating activities and spent $121.00K on capital expenditures. That left free cash flow of −$43.67M.

GH Research Cash Flow Statement Analysis

Values in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for GH Research PLC (GHRS) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
Operating Activities
Net Income-48.26-38.96-35.59-22.46-9.20-0.45-0.31
Depreciation & Amortization0.340.320.320.050.020.000.00
Deferred Income Tax0.000.000.000.00-5.920.000.00
Stock Based Compensation8.501.172.291.670.370.000.00
Change in Working Capital-3.090.191.652.16-0.560.120.02
Change in Other Working Capital8.330.19-8.26-1.04-0.560.120.02
Other Operating Activities-12.46-5.00-8.26-1.040.010.000.00
Net Cash from Operating Activities-43.55-42.29-33.34-26.20-15.28-0.33-0.29
Investing Activities
Capital Expenditures-0.12-0.05-0.10-0.07-0.100.000.00
Purchases of Investments0.000.00-54.00-84.620.000.000.00
Sales/Maturities of Investments46.2965.180.000.000.000.000.00
Net Cash from Investing Activities46.1765.14-54.10-84.69-0.100.000.00
Financing Activities
Debt Repayment-0.20-0.30-0.220.000.000.000.00
Common Stock Issued139.850.000.020.00309.205.500.80
Other Financing Activities-10.150.00-0.220.00-22.750.000.00
Net Cash from Financing Activities139.65-0.30-0.200.00286.455.500.80
Summary
Effect of Forex Changes on Cash3.19-0.180.110.07-0.180.23-0.01
Net Change in Cash145.4622.37-87.64-110.89270.885.400.50
Cash at Beginning of Period100.7978.42165.96276.785.900.500.00
Cash at End of Period246.25100.7978.42165.96276.785.900.50
Free Cash Flow-43.67-42.33-33.44-26.27-15.39-0.33-0.29
Supplemental Disclosures
Interest Paid-0.720.65-0.01--

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About GH Research Cash Flow

What is GH Research's free cash flow?

GH Research had negative free cash flow of $43.67M in fiscal 2025 (fiscal year ended Dec 31, 2025), operating cash flow of −$43.55M minus $121.00K of capital expenditures.

How much does GH Research spend on capital expenditures?

GH Research spent $121.00K on capital expenditures in fiscal 2025, compared with $49.00K a year earlier.

Does GH Research pay dividends or buy back shares?

GH Research's cash flow statement for fiscal 2025 shows no dividend payments or share repurchases.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition